CLINICAL_TRIALS
trial_result
· 2020-04-02
Clinical Trial Update: Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder [Phase 2]
Summary
Phase 2 trial update on ACT-541468 for insomnia disorder; results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Insomnia Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-04-02